( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

Cantech Letter

The Very Best of Canadian Science and Technology

Main Content

latest…

Canopy Rivers offers “best in class” exposure to the global cannabis sector: PI

Cannabis investment platform Canopy Rivers (Canopy Rivers Stock Quote, Chart TSXV:RIV) has announced … Keep reading

More recent headlines

See more stories

Cannabis

Canopy Rivers offers “best in class” exposure to the global cannabis sector: PI

By

Cannabis investment platform Canopy Rivers (Canopy Rivers Stock Quote, Chart TSXV:RIV) has announced that its subsidiary Spot Therapeutics has … Read More

See related

More Cannabis Articles

Invictus MD Interview

Stock Picks

OneSoft Solutions is nearly a double from here, Beacon Securities says

By

It's been one of the hottest stocks on the TSX Venture exchange, but Beacon Securities analyst Gabriel Leung thinks there is still plenty of runway … Read more

See related

See More Stock Picks

DMG Blockchain CEO interview

Life Sciences Stocks

Buy IMV for a double and then some, Echelon Wealth says

By

Echelon Wealth Partners analyst Doug Loe is holding steady on his estimation of IMV (IMV Stock … Keep reading

Sell Promis Neurosciences, Mackie Research says

By

An Alzheimer’s drug trial failure has caused Mackie Research analyst André Uddin to downgrade his … Keep reading

IMV has a 49 per cent upside, Mackie Research says

By

Biotech company IMV (IMV Stock Quote, Chart TSX:IMV) got a target reduction Friday from Mackie … Keep reading

Cipher Pharma has a huge upside, says Echelon Wealth

By

Look for Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart TSX:CPH) to break out of … Keep reading

Aurinia Pharma has a 56 per cent upside, Mackie Research says

By

Mackie Research analyst André Uddin is bullish on Canadian drug development company Aurinia … Keep reading